Showing results (371-380 of 1,671) with videos related to
Sort By:
Pageof 168
Cancers|March 28, 2026
Nerve-Sparing in High-Risk Prostate Cancer: Advantages and Pitfalls of Current Strategies and TechnologiesDaniele Robesti, Pierluigi Russo, Giuseppe Fallara, et al.Expert Opinion on Pharmacotherapy|August 29, 2014
Latest pharmacotherapy options for benign prostatic hyperplasiaAndrea Russo, Giovanni La Croce, Paolo Capogrosso, et al.Urologic Oncology|January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.Current Medical Research and Opinion|November 6, 2013
Naftopidil for the treatment of benign prostate hyperplasia: a systematic reviewFabio Castiglione, Fabio Benigni, Alberto Briganti, et al.Urologic Oncology|March 26, 2021
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand?Giuseppe Basile, Filippo Pederzoli, Marco Bandini, et al.European Urology Focus|January 25, 2023
Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective ReportsPawel Rajwa, Fabio Zattoni, Martina Maggi, et al.European Urology Oncology|May 18, 2019
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal MetastasesAxel Heidenreich, Nicola Fossati, David Pfister, et al.European Urology|May 1, 2012
Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgeryFabio Castiglione, Alice Bergamini, Arianna Bettiga, et al.BMJ (Clinical Research Ed.)|October 21, 2011
Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trialAntonella Crescenti, Giovanni Borghi, Elena Bignami, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|April 25, 2009
The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predictedUmberto Capitanio, Pierre I Karakiewicz, Claudio Jeldres, et al.Pageof 168